| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.085 | 0.007 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.009 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.01 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |